Mechanism of the glutathione transferase-catalyzed conversion of antitumor 2-crotonyloxymethyl-2-cycloalkenones to GSH adducts

Human glutathione (GSH) transferase (hGSTP1-1) processes with similar kinetic efficiencies the antitumor agents 2-crotonyloxymethyl-2-cyclohexenone (COMC-6), 2-crotonyloxymethyl-2-cycloheptenone (COMC-7), and 2-crotonyloxymethyl-2-cyclopentenone (COMC-5) to 2-glutathionylmethyl-2-cyclohexenone, 2-glutathionylmethyl-3-glutathionyl-2-cycloheptenone, and 2-glutathionylmethyl-2-cyclopentenone, respectively. This process likely involves initial enzyme-catalyzed Michael addition of GSH to the COMC derivative to give a glutathionylated enol(ate), which undergoes nonstereospecific ketonization, either while bound to the active site or free in solution, to a glutathionylated exocyclic enone. Free in solution, GSH reacts at the exomethylene carbon of the exocyclic enone, displacing the first GSH to give the final product. This mechanism is supported by the observation of multiphasic kinetics in the presence of high concentrations of hGSTP1-1 and the ability to trap kinetically competent exocyclic enones in aqueous acid using COMC-6 and COMC-7 as substrates. That the exocyclic enone is formed by nonstereospecific ketonization of an enol(ate) species is indicated by the observation that COMC-6 (chirally labeled with deuterium at the exomethylene carbon) gives stereorandomly labeled exocyclic enone. The isozymes hGSTP1-1, hGSTA1-1, hGSTA4-4, and hGSTM2-2 catalyze the conversion of COMC-6 to final product with similar efficiencies (K(m) = 0.08-0.34 mM, k(cat) = 1.5-6.1 s(-)(1)); no activity was detected with the rat rGSTT2-2 isozyme. Molecular docking studies indicate that in hGSTP1-1, the hydroxyl group of Tyr108 might serve as a general acid catalyst during substrate turnover. The possible significance of these observations with respect to the metabolism of COMC derivatives in multidrug resistant tumors is discussed.     

The `cyclophene' [2.2.2](1,2,4)cyclophan‐9‐ene

In the title compound, C₁₈H₁₆, the [2.2]paracyclophane geometry is restrained to a considerable extent despite the introduction of the extra C=C bridge; typical paracyclophane features, such as the elongated C—C bridges, are still observed. However, the bridgehead atoms of the C=C bridge are forced into unusually close proximity [2.657 (3) Å], which in turn causes the rings to be rotated to an interplanar angle of 13.7 (2)°. The packing involves hexagonally close‐packed layers of molecules parallel to the xy plane, corresponding to the known `7,11' pattern of paracyclophanes, but without significant short intermolecular contacts.     

C—H...π interactions in five ethynyl‐substituted [2.2]paracyclophanes: further examples of the `7,11' packing pattern

The monosubstituted derivative 4‐ethynyl[2.2]paracyclophane, C₁₈H₁₆, (I), and the four disubstituted isomers, 4,12‐, (II), 4,13‐, (III), 4,15‐, (IV), and 4,16‐diethynyl[2.2]paracyclophane, (V), all C₂₀H₁₆, show the usual distortions of the [2.2]paracyclophane framework. The crystal packing is analyzed in terms of C—H...π interactions, some with H...π as short as 2.47 Å, in which the cyclophane rings and/or the triple‐bond systems may act as acceptors. For compounds (I) and (IV), the known `7,11'‐type cyclophane packing is observed, with a herring‐bone pattern of molecules in a layer structure.     

5‐Methyl‐N‐[2‐nitro‐4‐(trifluoromethyl)phenyl]‐1H‐pyrazole‐3‐amine: a chain of hydrogen‐bonded R22(6) and R22(16) rings

The molecular skeleton of the title compound, C₁₁H₉F₃N₄O₂, is almost planar and exhibits a polarized (charge‐separated) electronic structure in the nitroaniline portion. Molecules are linked by N—H...N and C—H...O hydrogen bonds to form a chain in which centrosymmetric R₂²(6) and R₂²(16) rings alternate.